Glucose Control: non-insulin therapies*
This chapter summarises information for each of the non-insulin drug classes that are used for blood glucose control. Each summary is accompanied by a table of recommendations to guide the clinical use of these medications. For the sake of completeness, and for those that are interested, we have inc...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2018-03-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/4821 |
id |
doaj-2429b88a58bd4fa9839b790985cafca4 |
---|---|
record_format |
Article |
spelling |
doaj-2429b88a58bd4fa9839b790985cafca42020-11-25T03:27:38ZengAOSISSouth African Family Practice2078-61902078-62042018-03-0160141410.4102/safp.v60i1.48213816Glucose Control: non-insulin therapies*The Society for Endocrinology, Metabolism and Diabetes of South AfricaThis chapter summarises information for each of the non-insulin drug classes that are used for blood glucose control. Each summary is accompanied by a table of recommendations to guide the clinical use of these medications. For the sake of completeness, and for those that are interested, we have included a more detailed review of each drug as an appendix to each summary. These can be found in the Appendix section of the guidelines. The treatment recommendations for each drug have been incorporated into the treatment algorithm in Chapter 11. The following abbreviations are used in this chapter: DPP-4: dipeptidyl peptidase-4 GLP-1: glucagon-like peptide-1 SGLT2- sodium-glucose linked transporter-2https://safpj.co.za/index.php/safpj/article/view/4821glucose controlnon-insulin therapies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
The Society for Endocrinology, Metabolism and Diabetes of South Africa |
spellingShingle |
The Society for Endocrinology, Metabolism and Diabetes of South Africa Glucose Control: non-insulin therapies* South African Family Practice glucose control non-insulin therapies |
author_facet |
The Society for Endocrinology, Metabolism and Diabetes of South Africa |
author_sort |
The Society for Endocrinology, Metabolism and Diabetes of South Africa |
title |
Glucose Control: non-insulin therapies* |
title_short |
Glucose Control: non-insulin therapies* |
title_full |
Glucose Control: non-insulin therapies* |
title_fullStr |
Glucose Control: non-insulin therapies* |
title_full_unstemmed |
Glucose Control: non-insulin therapies* |
title_sort |
glucose control: non-insulin therapies* |
publisher |
AOSIS |
series |
South African Family Practice |
issn |
2078-6190 2078-6204 |
publishDate |
2018-03-01 |
description |
This chapter summarises information for each of the non-insulin drug classes that are used for blood glucose control. Each summary is accompanied by a table of recommendations to guide the clinical use of these medications. For the sake of completeness, and for those that are interested, we have included a more detailed review of each drug as an appendix to each summary. These can be found in the Appendix section of the guidelines. The treatment recommendations for each drug have been incorporated into the treatment algorithm in Chapter 11. The following abbreviations are used in this chapter:
DPP-4: dipeptidyl peptidase-4
GLP-1: glucagon-like peptide-1
SGLT2- sodium-glucose linked transporter-2 |
topic |
glucose control non-insulin therapies |
url |
https://safpj.co.za/index.php/safpj/article/view/4821 |
work_keys_str_mv |
AT thesocietyforendocrinologymetabolismanddiabetesofsouthafrica glucosecontrolnoninsulintherapies |
_version_ |
1724587933756817408 |